Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease trial. Demonstrated that CABG was superior to PCI in diabetic patients with multivessel coronary artery disease.
Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease trial. Demonstrated that CABG was superior to PCI in diabetic patients with multivessel coronary artery disease.
Our Heart Team provides expert second opinions with plain-language explanations. 24-hour turnaround.